Literature DB >> 28332760

Cytotoxic Essential Oils from Eryngium campestre and Eryngium amethystinum (Apiaceae) Growing in Central Italy.

Kevin Cianfaglione1,2, Evy E Blomme3, Luana Quassinti4, Massimo Bramucci4, Giulio Lupidi4, Stefano Dall'Acqua5, Filippo Maggi6.   

Abstract

Eryngium campestre and E. amethystinum are thorny herbs belonging to the Apiaceae family and spontaneously growing in stony pastures and dry meadows, preferentially on calcareous substrates. In the Mediterranean countries, these plants have been used as a food or traditional remedies to treat various ailments. In the present work, we have analyzed the chemical composition of the essential oils distilled from the aerial parts by GC-FID and GC/MS, and evaluated their cytotoxic effects on a panel of human cancer cells, namely A375 (human malignant melanoma), MDA-MB 231 cells (human breast adenocarcinoma), and HCT116 cells (human colon carcinoma), by the MTT assay. Furthermore, the Eryngium essential oils were evaluated for antioxidant and acetylcholinesterase (AChE) activities. The two essential oils were rich in sesquiterpene hydrocarbons, with germacrene D as the major compound, accompanied by allo-aromadendrene, β-elemene, spathulenol, and ledol. They turned out to be highly cytotoxic on the tumor cells, with IC50 values (1.65 - 5.32 and 1.57 - 2.99 μg/ml for E. amethystinum and E. campestre, respectively) comparable or close to those of the anticancer drug cisplatin. The E. amethystinum essential oil exhibited a moderate antioxidant activity, whereas that of E. campestre a weak AChE inhibition.
© 2017 Wiley-VHCA AG, Zurich, Switzerland.

Entities:  

Keywords:  zzm321990Eryngium amethystinumzzm321990; zzm321990Eryngium campestrezzm321990; Cytotoxic activities; Essential oils; Sesquiterpenes

Mesh:

Substances:

Year:  2017        PMID: 28332760     DOI: 10.1002/cbdv.201700096

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  7 in total

1.  Evaluation of anti-proliferative activity of Eryngium caucasicum on melanoma cancer cells.

Authors:  Haleh Forouhandeh; Zahra Rezaei Param; Ommoleila Molavi; Parina Asgharian; Vahideh Tarhriz
Journal:  BMC Complement Med Ther       Date:  2022-05-14

2.  Acorenone B: AChE and BChE Inhibitor as a Major Compound of the Essential Oil Distilled from the Ecuadorian Species Niphogeton dissecta (Benth.) J.F. Macbr.

Authors:  James Calva; Nicole Bec; Gianluca Gilardoni; Christian Larroque; Luis Cartuche; Carlo Bicchi; José Vinicio Montesinos
Journal:  Pharmaceuticals (Basel)       Date:  2017-10-31

Review 3.  Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma.

Authors:  Marta Di Martile; Stefania Garzoli; Rino Ragno; Donatella Del Bufalo
Journal:  Cancers (Basel)       Date:  2020-09-16       Impact factor: 6.639

4.  Chemical Composition of Essential Oils from Rare and Endangered Species-Eryngium maritimum L. and E. alpinum L.

Authors:  Małgorzata Kikowska; Danuta Kalemba; Jolanta Dlugaszewska; Barbara Thiem
Journal:  Plants (Basel)       Date:  2020-03-30

5.  Essential Oils from Two Apiaceae Species as Potential Agents in Organic Crops Protection.

Authors:  Nadjiya Merad; Vanessa Andreu; Slimane Chaib; Ronaldo de Carvalho Augusto; David Duval; Cédric Bertrand; Yacine Boumghar; André Pichette; Nassim Djabou
Journal:  Antibiotics (Basel)       Date:  2021-05-26

Review 6.  Eryngium foetidum L. (Apiaceae): A Literature Review of Traditional Uses, Chemical Composition, and Pharmacological Activities.

Authors:  Thiara L M Rodrigues; Maria E P Silva; Ely S C Gurgel; Mozaniel S Oliveira; Flavia C A Lucas
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-14       Impact factor: 2.629

7.  Chitosan nanoparticles containing limonene and limonene-rich essential oils: potential phytotherapy agents for the treatment of melanoma and breast cancers.

Authors:  Hiva Alipanah; Mojtaba Farjam; Elham Zarenezhad; Ghazaal Roozitalab; Mahmoud Osanloo
Journal:  BMC Complement Med Ther       Date:  2021-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.